Precise DAPT vs IVUSAID
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Precise DAPT
Read full descriptionHide full description
The PRECISE-DAPT score calculator provides the percentage probability of major bleeding at twelve months in patients with coronary artery disease treated with dual antiplatelet therapy after coronary stenting. This tool is designed to support clinicians decision making for dual antiplatelet therapy duration after coronary stenting. This calculator specifically designed for mobile devices, provides a rapid and intuitive assessment of patients' bleeding risk. Additional features include: – PRECISE-DAPT score calculation – Estimate of bleeding risk at 12-months for TIMI major and TIMI major or minor bleeding – Bleeding risk status according to the original score categories – Reporting system including all relevant information regarding the antiplatelet therapy selection and stenting procedure – An advanced e-mail reporting system to share information with the patient or other clinicians The PRECISE-DAPT score calculator includes 5 predictive risk factors to calculate the probability of major bleeding: Age Creatinin Clearance Haemoglobin levels White blood cell count History of previous spontaneous bleeding The score has been developed from a collaborative dataset including 14,963 patients from 8 randomized clinical trials, enrolled in more than 130 clinical sites and 12 countries worldwide. The PRECISE-DAPT Risk Score has been externally validated in two independent datasets. The PRECISE-DAPT Score and all related materials are for exclusive use of health care professionals and is intended as a supportive risk assessment tool which should never replace clinical judgment, physician–patient relationship or medical advice. Treatment risks and benefits should always be considered in the context of a comprehensive professional clinical assessment, taking into account all available data and treatment options. Physicians and other healthcare providers should always exercise their own clinical judgment for any given situation.
IVUSAID
This free educational app teaches medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance. It features interactive lessons, image interpretation tools, and complex case studies to overcome barriers to IVUS adoption.
- IVUS principles and image acquisition
- Image interpretation with videos and descriptions
- Complex coronary case studies
- Interactive quiz section with explanations
- PCI guidance for stent sizing and optimization
Read full descriptionHide full description
The IVUSAID App is a free educational mobile application which has been developed to teach medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance based on the current guidelines using our extensive experience and large database of complex coronary cases. Despite the growing body of evidence for clinical benefits of IVUS-guided PCI, IVUS remains underutilized in much of the world including the United States. Challenges in image interpretation and education are among the barriers to widespread adoption of IVUS in everyday clinical practice. Mount Sinai Heart is a global leader within the field of interventional cardiology as well as mobile apps development. The myriad of cases and pathology which are seen in The Mount Sinai Cardiac Catheterization Laboratory make it the perfect center to educate medical professionals within this field. The Key Concepts section of IVUSAID describes principles of IVUS, image acquisition, and concepts of ultrasound behavior in various tissues. The Image Interpretation section of the app has dozens of representative cross-sectional images, videos, and descriptions of plaque types, stent apposition and expansion, artifacts, and more. A short video for each type of lesion or artifact and post-stent findings, in addition to an annotated representative cross section aims to overcome a major limitation of any article or book on IVUS which present a static image, since the actual IVUS pullback is dynamic. Twenty-one complex coronary cases demonstrate IVUS guidance in a variety of patient presentations and lesions including ACS, LM bifurcation, severely calcified lesions and calcified nodules, spontaneous coronary artery dissection, and malapposed stents as well as how IVUS was used to inform treatment decisions. An extensive quiz section helps deliver educational content in a more interactive format where answers are accompanied by detailed explanations and references. We hope that IVUSAID will help techs, fellows, and early-career physicians incorporate IVUS in their daily practice for stent sizing, post-stent optimization, and identification of appropriate treatment strategies.
Screenshots
Verdict
The clearest difference is ads: Precise DAPT at none against IVUSAID's shown. Precise DAPT also leads on update cadence (every 2 weeks vs every 18 months) and iOS requirement (8.0 vs 15.0). On price, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Precise DAPT ships an update every 2 weeks, IVUSAID every 18 months. The most recent releases landed on October 1, 2026 and October 2, 2026 respectively.
| Parameter | Precise DAPT | IVUSAID |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | Every 2 weeks — better | Every 18 months |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | — | Ad-supported |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 8.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 55 MB | 80 MB |
| Age rating | 17+ | 17+ |
| Developer | Alma Digit Srl | Cardiology Apps LLC |
In-app purchases
Precise DAPT
No in-app purchases
IVUSAID
No in-app purchases









